Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.

Wang Y, He Y, Qin Z, Jiang Y, Jin G, Ma H, Dai J, Chen J, Hu Z, Guan X, Shen H.

Breast Cancer Res. 2014 Aug 14;16(4):422.

PMID:
25116933
[PubMed - as supplied by publisher]
Free PMC Article
2.

Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, Hartman M.

Breast Cancer Res. 2014 Jun 18;16(3):R64. doi: 10.1186/bcr3678.

PMID:
24941967
[PubMed - in process]
Free PMC Article
3.

Common low-penetrance risk variants associated with breast cancer in Polish women.

Ledwoń JK, Hennig EE, Maryan N, Goryca K, Nowakowska D, Niwińska A, Ostrowski J.

BMC Cancer. 2013 Oct 30;13:510. doi: 10.1186/1471-2407-13-510.

PMID:
24171766
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.

Wang X, Zhang L, Chen Z, Ma Y, Zhao Y, Rewuti A, Zhang F, Fu D, Han Y.

PLoS One. 2013 Sep 6;8(9):e73611. doi: 10.1371/journal.pone.0073611. eCollection 2013.

PMID:
24039999
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.

Yu Y, Chen Z, Wang H, Zhang Y.

PLoS One. 2013 Aug 19;8(8):e72154. doi: 10.1371/journal.pone.0072154. eCollection 2013.

PMID:
23977236
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.

Huang T, Hong J, Lin W, Yang Q, Ni K, Wu Q, Sun J.

PLoS One. 2013 Aug 16;8(8):e69056. doi: 10.1371/journal.pone.0069056. eCollection 2013.

PMID:
23976942
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.

Gu C, Zhou L, Yu J.

PLoS One. 2013 Jul 22;8(7):e66979. doi: 10.1371/journal.pone.0066979. Print 2013.

PMID:
23894282
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.

Liyanarachchi S, Wojcicka A, Li W, Czetwertynska M, Stachlewska E, Nagy R, Hoag K, Wen B, Ploski R, Ringel MD, Kozłowicz-Gudzinska I, Gierlikowski W, Jazdzewski K, He H, de la Chapelle A.

Thyroid. 2013 Dec;23(12):1532-40. doi: 10.1089/thy.2013.0102. Epub 2013 Aug 29.

PMID:
23659773
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis.

Guo H, Ming J, Liu C, Li Z, Zhang N, Cheng H, Wang W, Shi W, Shen N, Zhao Q, Li D, Yi P, Wang L, Wang R, Xin Y, Zhao X, Nie X, Huang T.

PLoS One. 2012;7(12):e52445. doi: 10.1371/journal.pone.0052445. Epub 2012 Dec 18.

PMID:
23272245
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.

Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, Kang D, Yoo KY, Noh DY, Ahn SH, Dork T, Schürmann P, Karstens JH, Hillemanns P, Couch FJ, Olson J, Vachon C, Wang X, Cox A, Brock I, Elliott G, Reed MW, Burwinkel B, Meindl A, Brauch H, Hamann U, Ko YD; GENICA Network, Broeks A, Schmidt MK, Van 't Veer LJ, Braaf LM, Johnson N, Fletcher O, Gibson L, Peto J, Turnbull C, Seal S, Renwick A, Rahman N, Wu PE, Yu JC, Hsiung CN, Shen CY, Southey MC, Hopper JL, Hammet F, Van Dorpe T, Dieudonne AS, Hatse S, Lambrechts D, Andrulis IL, Bogdanova N, Antonenkova N, Rogov JI, Prokofieva D, Bermisheva M, Khusnutdinova E, van Asperen CJ, Tollenaar RA, Hooning MJ, Devilee P, Margolin S, Lindblom A, Milne RL, Arias JI, Zamora MP, Benítez J, Severi G, Baglietto L, Giles GG; kConFab; AOCS Study Group, Spurdle AB, Beesley J, Chen X, Holland H, Healey S, Wang-Gohrke S, Chang-Claude J, Mannermaa A, Kosma VM, Kauppinen J, Kataja V, Agnarsson BA, Caligo MA, Godwin AK, Nevanlinna H, Heikkinen T, Fredericksen Z, Lindor N, Nathanson KL, Domchek SM; SWE-BRCA, Loman N, Karlsson P, Stenmark Askmalm M, Melin B, von Wachenfeldt A; HEBON, Hogervorst FB, Verheus M, Rookus MA, Seynaeve C, Oldenburg RA, Ligtenberg MJ, Ausems MG, Aalfs CM, Gille HJ, Wijnen JT, Gómez García EB; EMBRACE, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Pichert G, Davidson R, Chu C, Eccles D, Ong KR, Cook J, Douglas F, Hodgson S, Evans DG, Eeles R, Gold B, Pharoah PD, Offit K, Chenevix-Trench G, Easton DF; BCAC/CIMBA.

PLoS One. 2012;7(6):e35706. doi: 10.1371/journal.pone.0035706. Epub 2012 Jun 29.

PMID:
22768030
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk